We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

4 hedge funds and large institutions have $11.2M invested in Cyteir Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

71% less capital invested

Capital invested by funds: $38.9M → $11.2M (-$27.7M)

89% less funds holding

Funds holding: 38 → 4 (-34)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 35

Holders
4
Holders Change
-34
Holders Change %
-89.47%
% of All Funds
0.06%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
1
Reduced
–
Closed
35
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
BML Capital Management
Indiana
+$1.25M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$81.4K

Top Sellers

Rank Fund Capital Flow
1
NM
Newtyn Management
New York
-$9.19M
2
GF
Gabelli Funds
New York
-$3.37M
3
AFM
Anson Funds Management
Texas
-$3.33M
4
GCIA
Gabelli & Co Investment Advisers
New York
-$3.12M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$2.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
– -$99.7K -32,800 Closed
WIM
27
Wittenberg Investment Management
Massachusetts
– -$86.9K -28,588 Closed
CCM
28
CAAS Capital Management
New York
– -$79.6K -26,175 Closed
HF
29
HRT Financial
New York
– -$48K -16,015 Closed
Charles Schwab
30
Charles Schwab
California
– -$48.6K -15,972 Closed
LCM
31
Landscape Capital Management
New Jersey
– -$39.8K -13,080 Closed
XT
32
XTX Topco
Cayman Islands
– -$32.2K -10,596 Closed
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
– -$16K -5,357 Closed
TRCT
34
Tower Research Capital (TRC)
New York
– -$9.27K -3,049 Closed
Morgan Stanley
35
Morgan Stanley
New York
– -$6.08K -2,000 Closed
WAM
36
Wolverine Asset Management
Illinois
– -$1.73K -570 Closed
Wells Fargo
37
Wells Fargo
California
– -$447 -147 Closed
JP Morgan Chase
38
JP Morgan Chase
New York
– -$377 -124 Closed
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
– -$12 -4 Closed
1
2

CYT Hedge Fund Activity: Q1 2024 in Review

4 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q1 2024, worth a combined $11.2M — down 71% from $38.9M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of CYT and 1 opened new positions — a net loss of 34 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was BML Capital Management, adding an estimated $1.25M. The largest seller was Newtyn Management, exiting entirely with an estimated $9.19M sold.

  • 4 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q1 2024, down from 38 in Q4 2023.
  • Funds reported $11.2M of Cyteir Therapeutics, Inc. Common Stock stock for Q1 2024, down 71% quarter-over-quarter.
  • 1 fund opened new Cyteir Therapeutics, Inc. Common Stock positions in Q1 2024 and 35 closed out, a net change of -34 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q1 2024 was BML Capital Management, an estimated $1.25M added.
  • The largest Cyteir Therapeutics, Inc. Common Stock seller in Q1 2024 was Newtyn Management, an estimated $9.19M sold.

Based on aggregated 13F filings for Q1 2024.